Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3-Year Results from the Phase 3 MEASURE 3 Study
| Image |  |
|---|---|
| Description | scientific article published on 20 January 2020 |
| Author/s |
author: Eva Dokoupilova Brian Porter Karel Pavelka |
| Publication date | January 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |